Nifty
:
14984.45
Sensex
:
50641.84
46.35 (0.31%)
236.52 (0.47%)
Nifty
Sensex
:
:
14984.45
50641.84
46.35 (0.31%)
236.52 (0.47%)

Themis Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
39/99

BSE: 530199 | NSE: THEMISMED

NSE BSE
311.10
05-Mar-2021
  • Open
  • High
  • Low
  • Previous Close
  •  315.25
  •  318.50
  •  308.05
  •  312.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  9472
  •  29.57
  •  422.90
  •  225.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 285.81
  • 8.18
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 380.23
  • 0.56%
  • 1.52

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.26%
  • 3.55%
  • 23.23%
  • FII
  • DII
  • Others
  • 0.01%
  • 0.00%
  • 5.95%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.21
  • -2.81
  • -1.27

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.20
  • -1.34
  • 7.78

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.37
  • 0.85
  • 22.21

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.05
  • 23.56
  • 22.37

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.50
  • 2.84
  • 1.91

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.22
  • 20.59
  • 24.73

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
65.52
53.78
21.83%
54.89
50.32
9.08%
48.49
51.33
-5.53%
46.15
35.71
29.24%
Expenses
50.27
44.45
13.09%
45.19
44.89
0.67%
36.19
43.83
-17.43%
32.77
41.92
-21.83%
EBITDA
15.25
9.33
63.45%
9.70
5.43
78.64%
12.30
7.51
63.78%
13.39
-6.21
-
EBIDTM
23.28%
17.35%
17.67%
10.79%
25.36%
14.63%
29.00%
-17.38%
Other Income
0.25
2.91
-91.41%
2.13
0.08
2,562.50%
0.36
0.09
300.00%
0.38
1.72
-77.91%
Interest
2.92
2.96
-1.35%
3.71
3.30
12.42%
3.00
3.21
-6.54%
3.41
2.92
16.78%
Depreciation
2.09
2.07
0.97%
2.04
2.06
-0.97%
2.04
2.07
-1.45%
2.07
2.05
0.98%
PBT
10.49
7.22
45.29%
6.08
0.14
4,242.86%
7.62
2.33
227.04%
8.29
-9.46
-
Tax
2.02
-0.31
-
0.42
-0.49
-
1.98
-0.20
-
3.09
-0.17
-
PAT
8.47
7.53
12.48%
5.66
0.63
798.41%
5.64
2.53
122.92%
5.19
-9.29
-
PATM
12.92%
14.00%
10.31%
1.25%
11.63%
4.92%
11.25%
-26.02%
EPS
12.80
11.62
10.15%
8.85
1.83
383.61%
8.44
5.62
50.18%
7.92
-10.79
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
215.05
201.59
183.75
209.50
216.66
232.43
201.88
195.07
173.51
157.72
252.08
Net Sales Growth
12.51%
9.71%
-12.29%
-3.30%
-6.78%
15.13%
3.49%
12.43%
10.01%
-37.43%
 
Cost Of Goods Sold
65.95
51.97
58.82
57.75
55.66
71.38
79.51
76.68
74.95
94.19
135.16
Gross Profit
149.10
149.62
124.94
151.75
160.99
161.06
122.37
118.39
98.56
63.52
116.91
GP Margin
69.33%
74.22%
67.99%
72.43%
74.31%
69.29%
60.62%
60.69%
56.80%
40.27%
46.38%
Total Expenditure
164.42
165.93
181.48
184.98
184.29
194.28
183.91
171.01
156.71
170.56
228.45
Power & Fuel Cost
-
11.49
9.70
8.41
9.77
10.83
8.36
10.04
10.03
10.27
11.47
% Of Sales
-
5.70%
5.28%
4.01%
4.51%
4.66%
4.14%
5.15%
5.78%
6.51%
4.55%
Employee Cost
-
44.28
45.69
44.65
40.00
36.30
32.64
31.14
27.27
23.70
22.22
% Of Sales
-
21.97%
24.87%
21.31%
18.46%
15.62%
16.17%
15.96%
15.72%
15.03%
8.81%
Manufacturing Exp.
-
24.01
22.45
27.46
31.30
31.28
21.69
16.38
11.80
12.36
29.15
% Of Sales
-
11.91%
12.22%
13.11%
14.45%
13.46%
10.74%
8.40%
6.80%
7.84%
11.56%
General & Admin Exp.
-
14.05
17.57
18.93
18.86
14.75
13.52
11.72
11.33
9.75
10.40
% Of Sales
-
6.97%
9.56%
9.04%
8.70%
6.35%
6.70%
6.01%
6.53%
6.18%
4.13%
Selling & Distn. Exp.
-
12.28
17.71
18.27
16.70
12.05
10.87
10.06
7.65
5.89
7.90
% Of Sales
-
6.09%
9.64%
8.72%
7.71%
5.18%
5.38%
5.16%
4.41%
3.73%
3.13%
Miscellaneous Exp.
-
7.86
9.54
9.51
11.99
17.69
17.32
14.98
13.68
14.40
7.90
% Of Sales
-
3.90%
5.19%
4.54%
5.53%
7.61%
8.58%
7.68%
7.88%
9.13%
4.82%
EBITDA
50.64
35.66
2.27
24.52
32.37
38.15
17.97
24.06
16.80
-12.84
23.63
EBITDA Margin
23.55%
17.69%
1.24%
11.70%
14.94%
16.41%
8.90%
12.33%
9.68%
-8.14%
9.37%
Other Income
3.12
3.46
2.67
3.49
3.32
3.19
12.59
4.90
3.34
2.94
5.66
Interest
13.04
12.88
11.82
11.87
11.84
12.33
14.53
15.63
15.28
13.55
10.38
Depreciation
8.24
8.27
7.99
7.42
7.47
11.89
11.49
9.36
8.91
7.67
7.74
PBT
32.48
17.97
-14.87
8.74
16.37
17.13
4.54
3.98
-4.05
-31.12
11.17
Tax
7.51
2.09
-1.84
0.10
1.60
1.91
-0.89
1.28
2.27
1.35
-0.23
Tax Rate
23.12%
11.63%
12.37%
1.14%
9.77%
11.15%
-19.60%
32.16%
-56.05%
-4.34%
-2.06%
PAT
24.96
15.88
-13.01
8.70
14.77
15.22
5.44
2.70
-6.32
-32.47
11.40
PAT before Minority Interest
24.96
15.88
-13.03
8.64
14.77
15.22
5.44
2.70
-6.32
-32.47
11.40
Minority Interest
0.00
0.00
0.02
0.06
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.61%
7.88%
-7.08%
4.15%
6.82%
6.55%
2.69%
1.38%
-3.64%
-20.59%
4.52%
PAT Growth
1,682.86%
-
-
-41.10%
-2.96%
179.78%
101.48%
-
-
-
 
EPS
27.13
17.26
-14.14
9.46
16.05
16.54
5.91
2.93
-6.87
-35.29
12.39

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
183.02
158.09
168.91
152.44
74.03
59.20
56.53
52.17
58.52
91.56
Share Capital
9.19
9.18
9.18
9.04
8.52
8.47
8.45
8.05
8.05
8.05
Total Reserves
173.35
148.31
159.18
141.36
65.51
50.73
48.08
43.27
50.47
83.51
Non-Current Liabilities
7.51
2.71
6.72
7.60
70.83
82.04
89.97
99.37
71.58
67.61
Secured Loans
0.09
0.14
0.01
0.47
15.89
18.83
24.47
32.08
2.78
0.06
Unsecured Loans
11.76
9.21
11.48
11.93
47.52
55.81
52.30
59.72
62.13
60.83
Long Term Provisions
0.00
0.00
0.00
0.00
0.54
0.49
0.46
0.39
0.30
1.24
Current Liabilities
154.81
146.69
124.94
124.17
129.66
135.61
137.09
120.36
150.31
134.08
Trade Payables
29.68
35.04
30.55
31.63
34.90
60.15
56.97
51.65
59.03
64.17
Other Current Liabilities
46.86
43.72
29.76
38.13
37.04
16.51
23.68
14.81
12.93
10.60
Short Term Borrowings
76.61
66.86
63.73
53.45
51.88
53.78
52.74
50.55
75.35
54.15
Short Term Provisions
1.66
1.07
0.90
0.95
5.83
5.17
3.71
3.34
3.00
5.16
Total Liabilities
345.34
307.47
300.51
284.21
274.52
276.85
283.59
271.90
280.41
293.25
Net Block
116.31
123.41
125.90
123.71
117.35
122.32
121.26
123.66
133.75
118.75
Gross Block
147.14
146.06
140.78
131.17
212.16
206.19
192.01
185.14
187.89
165.44
Accumulated Depreciation
30.83
22.66
14.87
7.46
94.80
83.87
70.75
61.47
54.14
46.69
Non Current Assets
164.85
157.61
157.47
159.81
141.68
143.38
149.17
148.01
151.01
149.69
Capital Work in Progress
7.54
2.45
2.47
8.95
5.79
3.50
11.63
10.70
6.77
16.89
Non Current Investment
35.47
26.64
24.38
21.83
5.64
4.59
3.59
3.59
0.51
0.51
Long Term Loans & Adv.
2.91
2.67
2.39
3.01
12.19
12.70
12.11
9.79
9.54
12.02
Other Non Current Assets
2.62
2.45
2.33
2.30
0.70
0.28
0.58
0.27
0.45
1.52
Current Assets
180.49
149.86
143.04
124.40
132.83
133.47
134.44
123.89
129.40
143.57
Current Investments
0.00
0.00
0.00
1.05
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
54.61
53.63
49.58
48.44
58.26
62.30
66.34
54.70
47.23
46.26
Sundry Debtors
102.48
72.91
68.63
48.25
47.57
45.56
39.58
32.35
48.13
66.57
Cash & Bank
5.29
3.45
6.91
8.62
14.30
8.70
6.57
12.21
6.70
6.18
Other Current Assets
18.11
5.42
5.34
5.32
12.70
16.92
21.94
24.63
27.35
24.55
Short Term Loans & Adv.
12.28
14.45
12.57
12.72
11.34
15.58
20.57
23.22
26.34
22.62
Net Current Assets
25.68
3.18
18.09
0.23
3.18
-2.14
-2.66
3.53
-20.92
9.49
Total Assets
345.34
307.47
300.51
284.21
274.51
276.85
283.61
271.90
280.41
293.26

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
0.33
10.92
7.86
-1.51
25.76
19.09
8.35
4.45
-14.33
4.49
PBT
26.87
-12.60
11.33
17.56
30.52
19.85
19.61
11.23
-17.57
20.55
Adjustment
9.33
16.74
14.93
15.92
10.05
10.48
8.47
7.72
6.80
6.26
Changes in Working Capital
-35.63
7.08
-19.05
-35.16
-0.57
2.40
-2.82
3.04
11.34
-11.62
Cash after chg. in Working capital
0.57
11.22
7.21
-1.67
40.00
32.73
25.26
22.00
0.57
15.19
Interest Paid
0.00
0.00
0.00
0.00
-12.33
-14.53
0.00
0.00
0.00
0.00
Tax Paid
-0.24
-0.30
0.65
0.16
-1.91
0.89
-1.28
-2.27
-1.35
-0.40
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.47
-3.72
-0.04
-4.14
-7.17
-6.27
-6.71
-4.56
-11.76
-9.17
Net Fixed Assets
-6.16
-5.34
-3.11
20.82
-6.64
-2.13
-3.68
2.13
-7.75
-11.11
Net Investments
0.06
-0.01
1.01
-1.33
0.01
-0.23
0.00
-3.09
-0.01
0.00
Others
0.63
1.63
2.06
-23.63
-0.54
-3.91
-3.03
-3.60
-4.00
1.94
Cash from Financing Activity
6.72
-9.94
-9.11
5.27
-13.29
-17.96
1.89
29.33
4.93
-2.50
Net Cash Inflow / Outflow
1.59
-2.74
-1.29
-0.38
5.31
-5.14
3.52
29.23
-21.16
-7.18
Opening Cash & Equivalents
1.75
4.49
5.78
6.16
-39.67
-34.53
-38.05
-67.28
-46.12
-39.01
Closing Cash & Equivalent
3.34
1.75
4.49
5.78
-34.36
-39.67
-34.53
-38.05
-67.28
-46.19

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
198.67
171.54
183.39
166.38
86.94
69.91
66.90
63.75
72.69
113.74
ROA
4.86%
-4.29%
2.95%
5.29%
5.52%
1.94%
0.97%
-2.29%
-11.32%
4.00%
ROE
9.34%
-8.00%
5.42%
13.16%
22.85%
9.40%
5.00%
-11.50%
-43.27%
13.00%
ROCE
11.81%
-1.25%
8.52%
12.92%
14.69%
9.45%
9.53%
5.39%
-8.28%
10.20%
Fixed Asset Turnover
1.38
1.28
1.56
1.32
1.13
1.03
1.04
0.94
0.91
1.57
Receivable days
158.78
140.57
100.75
77.33
72.04
76.05
66.90
83.91
130.33
87.40
Inventory Days
97.99
102.51
84.49
86.11
93.26
114.91
112.58
106.28
106.24
62.74
Payable days
75.58
71.78
69.42
73.88
99.57
126.74
123.69
137.24
142.68
90.57
Cash Conversion Cycle
181.20
171.29
115.83
89.56
65.73
64.22
55.79
52.95
93.89
59.57
Total Debt/Equity
0.55
0.52
0.48
0.55
1.73
2.37
2.61
3.02
2.57
1.35
Interest Cover
2.40
-0.26
1.74
2.38
2.39
1.31
1.25
0.74
-1.30
2.08

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.